Evidence map›Paper›PMID 35884116›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Inactivation of Bacteria and Residual Antimicrobials in Hospital Wastewater by Ozone Treatment.

Takashi Azuma, Miwa Katagiri, Tsuyoshi Sekizuka, Makoto Kuroda, Manabu Watanabe

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Takashi AzumaDepartment of Pharmaceutical Sciences, Osaka Medical and Pharmaceutical University, Takatsuki 569-1094, Japan.
Miwa KatagiriDepartment of Surgery, Toho University Ohashi Medical Center, Tokyo 153-8515, Meguro-ku, Japan.ORCID 0000-0001-5894-4563
Tsuyoshi SekizukaPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo 162-8640, Shinjyuku-ku, Japan.
Makoto KurodaPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo 162-8640, Shinjyuku-ku, Japan.ORCID 0000-0002-0487-4405
Manabu WatanabeDepartment of Surgery, Toho University Ohashi Medical Center, Tokyo 153-8515, Meguro-ku, Japan.ORCID 0000-0002-8916-4663
National Institute of Infectious Diseases · JPToho University · JPOsaka University of Pharmaceutical Sciences · JP

Funding

Japan Agency for Medical Research and Development JP22fk0108131research on emerging and reemerging infectious diseases and immunization from the Ministry of Health, Labour and Welfare 21HA1002research on emerging and reemerging infectious diseases and immunization from the Ministry of Health, Labour and Welfare H30 Shinkogyo-sei-Ippan-002
6 · The paper itself

Abstract

The emergence and spread of antimicrobial resistance (AMR) has become a persistent problem globally. In this study, an ozone treatment facility was established for an advanced hospital wastewater treatment in a core hospital facility in an urban area in Japan to evaluate the inactivation of antimicrobial-resistant bacteria and antimicrobials. Metagenomic DNA-seq analysis and the isolation of potential extended-spectrum

Indexed as

carbapenemaseenterobacteriaceaeextended-spectrum β-lactamase (ESBL)hospital wastewatermetagenomicsozone treatmentresidual antimicrobials

Identifiers

PMID35884116
PMCPMC9311624
OpenAlexW4283660059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.